Acetylshikonin Eases Gouty Arthritis via Sirtuin1 Boost
Researchers led by Wu, C. demonstrated that acetylshikonin, a plant‑derived molecule, markedly increases SIRT1 expression in gouty arthritis models. The up‑regulation of SIRT1 coincided with significant drops in IL‑1β and TNF‑α levels, curbing joint inflammation. In parallel, the compound boosted lymphatic vessel density, enhancing fluid drainage and reducing swelling. These pre‑clinical results position acetylshikonin as a promising, natural alternative to conventional gout therapies.
STAT+: A Sign Biotech Is Back? Four Drugmakers Go Public, Raising Nearly $1 Billion in All
Four biotech firms—Agomab Therapeutics, Eikon Therapeutics, Spyglass Pharma, and Veradermics—went public this week, collectively raising close to $1 billion. A fifth company, Generate Biomedicines, filed IPO paperwork, signaling renewed confidence in public markets. The wave follows a prolonged downturn where only...
Maturing Heart-Lung Sync Reveals Preterm Infant Health
Researchers have identified cardiopulmonary phase synchronization as a robust biomarker for autonomic nervous system maturation in preterm infants. By applying Hilbert‑transform‑based signal processing to continuous ECG and respiratory waveforms, the study mapped a clear maturational trajectory that correlates with gestational...
White House’s Online Service for Drug Sales Debuts with Limited Impact on Prices
The White House launched TrumpRx, an online portal selling about 40 prescription drugs from manufacturers such as Pfizer, Eli Lilly, and Novo Nordisk at discounted rates. The platform targets cash‑pay consumers, offering "most‑favored‑nation" pricing that mirrors low overseas prices. While the service...
Simulation Finds Grass2Gas Biogas Systems May Reduce Dairy Emissions by over 20%
A Penn State-led simulation of the Grass2Gas system—combining year‑round cover crops with anaerobic digestion of manure and biomass—shows an average reduction of more than 20% in the carbon footprint of milk from a typical Pennsylvania dairy. Life‑cycle assessment reveals that...
How CDMO Alliances Can Provide End-to-End Service that Reduces Drug Development Time and Costs
Integrated CDMO networks are reshaping drug development by offering end‑to‑end expertise, especially for complex modalities such as antibody‑drug conjugates (ADCs). Partnerships between specialist CDMOs allow small and mid‑size biopharma firms to access high‑potency handling, bioconjugation, and lyophilization capabilities without building...
Researchers Uncover Novel CDK12-FOXA1 Pathway Driving Prostate Cancer Progression—Team Led by Professor Jun Pang at Sun Yat-Sen University Reveals New...
Researchers led by Jun Pang at Sun Yat‑Sen University identified a CDK12‑FOXA1 signaling axis that drives prostate cancer progression. CDK12 phosphorylates FOXA1 at serine 234, enhancing its transcriptional potency and up‑regulating MDM2, which in turn degrades the tumor‑suppressor p53. Inhibiting CDK12 with...
Hovione’s Strategy for Complexity, Speed, and Regional Supply Chains
Marcio Temtem, Hovione’s VP of Strategic Business Management, highlighted three industry shifts: growing small‑molecule complexity, faster development cycles driven by AI, and the regionalization of supply chains. Hovione counters these pressures with its amorphous solid dispersion platform, continuous flow and...
Editors Bridging Science: From Desk to Lab
The role of scientific journal editors is evolving from pure gatekeeping to active participation in laboratory research, as highlighted by Guo and Ding’s analysis in Light: Science & Applications. By immersing themselves in cutting‑edge fields such as photonics and quantum...
AI Diagnoses Cervical Spondylosis via Multimodal Imaging
Researchers led by Song, Li, and Ouyang introduced a multi‑task deep‑learning model that simultaneously analyzes MRI, CT and X‑ray scans to diagnose cervical spondylosis. Trained on thousands of annotated multimodal images, the system captures bony, disc and neural pathologies with...
UniQure Pauses Higher Doses in Fabry Study; Aro Shares Pompe Data
UniQure announced a pause on the mid‑ and high‑dose cohorts of its Fabry disease gene‑therapy trial after two participants receiving 4×10^13 genome copies per kilogram experienced safety concerns. The low‑dose arm will continue while the company conducts a detailed safety...
How AI Is Helping Solve the Labor Issue in Treating Rare Diseases
Biotech firms Insilico Medicine and GenEditBio are leveraging artificial intelligence to overcome the talent bottleneck that has left thousands of rare diseases untreated. Insilico’s new MMAI Gym trains large language models to perform multiple drug‑discovery tasks, while its platform automates...
Weill Cornell Physician-Scientists Honored with ASCI Early-Career Awards
Weill Cornell Medicine announced that Dr. Semra Etyemez and Dr. Jesse Platt received the American Society for Clinical Investigation’s 2026 early‑career honors. Etyemez earned the Emerging‑Generation Award for her work identifying biomarkers of perinatal mood and anxiety disorders, while Platt...
Texas Children’s Establishes National Benchmark in Pediatric Organ Transplantation
Texas Children’s Hospital reclaimed the national lead for pediatric organ transplantation by completing 144 transplants in 2025, a 22% rise over its 2021 record. The hospital now tops the United States in liver and kidney transplant volume and shares the...
Leqembi Starts to Deliver for Eisai and Biogen
Biogen and Eisai reported a 54% jump in fourth‑quarter sales of their Alzheimer’s drug Leqembi, reaching $134 million, with $78 million generated in the United States. The increase follows the FDA’s approval of a once‑weekly subcutaneous injection, offering a less‑burdensome alternative to...
Tandem Repeat Evolution Under Selfing and Selection
A new study by Sudbrack and Mullon shows that partial self‑fertilisation dramatically reshapes the evolution of tandem repeat (TR) sequences. Selfing increases homozygosity, amplifying variance from unequal recombination and strengthening selection across four regimes, resulting in lower genetic load despite...
UMD Researchers Detect E. Coli and Other Pathogens in Potomac River Following Sewage Spill
University of Maryland researchers confirmed elevated concentrations of E. coli and several other pathogenic bacteria in the Potomac River after a recent sewage overflow. The study, conducted within weeks of the incident, found contaminant levels far above EPA recreational water...
University of Houston Research Uncovers Promising New Targets for Dyslexia Detection and Treatment
University of Houston researchers led by Elena Grigorenko synthesized four decades of genetic data, analyzing 175 candidate genes linked to dyslexia. Their systematic review, published in the Journal of Speech, Language, and Hearing Research, reveals that reading difficulties stem from...
From Photo Film Maker To Biopharma Giant
Fujifilm Biotechnologies, a subsidiary of the historic photo‑film maker, opened a 150‑acre, commercial‑scale biopharma manufacturing campus in Holly Springs, North Carolina, investing over $3.2 billion. The first phase features eight 20,000‑liter mammalian cell‑culture bioreactors, with a second phase slated to double...
Top Biotech Deals in January 2026
January 2026 saw a slowdown in headline biopharma M&A, yet the deals that closed were strategically sizable. Amgen bought Dark Blue Therapeutics for $840 million, adding an AML protein‑degrader, while GSK acquired RAPT Therapeutics for $2.2 billion to expand its anti‑IgE portfolio....
Scientists Reveal Microalgae’s Unexpected Role in Spreading Antibiotic Resistance in Waterways
Scientists have identified the phycosphere surrounding microalgae as a hidden hotspot for antibiotic resistance genes (ARGs) in freshwater systems. Organic exudates from algae attract bacteria that exchange ARGs through heightened horizontal gene transfer within dense biofilms. Nutrient runoff and algal...
Papadelis Appointed Head of New Pediatric Brain Research Center
Christos Papadelis has been appointed founding director of the Pediatric Brain Health and Neurosciences Center at the University of Texas at Arlington. The R1‑designated center will unite neurologists, bioengineers, data scientists and child‑health experts to accelerate translational research. Papadelis’s team...
Revolutionary iMRI Technology at UChicago Medicine Enhances Safety, Speed, and Precision in Brain Surgery
UChicago Medicine has deployed a new intra‑operative magnetic resonance imaging (iMRI) suite that integrates real‑time imaging with neurosurgical navigation. The system shortens brain tumor resections by up to 30%, reduces postoperative complications by 20%, and allows surgeons to verify complete...
Most Side Effects Listed for Statins in Package Leaflets Are Not Actually Caused by the Drugs, New Research Finds
A new Lancet meta‑analysis of 23 randomized statin trials involving over 150,000 participants finds that most side effects listed on statin package leaflets are not caused by the drugs. The study reports no statistically significant increase in cognitive impairment, depression,...
The Download: Helping Cancer Survivors to Give Birth, and Cleaning up Bangladesh’s Garment Industry
An experimental surgical technique that temporarily removes the uterus, ovaries and fallopian tubes during colorectal cancer treatment has enabled a fifth baby, Lucien, to be born in Europe, marking the first successful post‑treatment birth on the continent. The same newsletter...
Drug Digest: Outsourcing Partnerships Fuel Global Biopharma Discovery and Scale-Up
Strategic outsourcing is reshaping biopharma by linking discovery, formulation, and early‑clinical manufacturing through specialized external partners. In a Drug Digest interview, iOrganBio CEO Daniel Delubac explains how risk‑focused partner selection and integrated data flows accelerate cell, gene, and RNA therapies...
Ginkgo’s GPT-5 Lab Cuts Protein Synthesis Costs by 40%
Ginkgo Bioworks, in partnership with OpenAI, deployed a GPT‑5‑driven autonomous lab that designed, executed, and learned from 36,000 cell‑free protein synthesis experiments. Over six iterative cycles, the system cut reaction component costs by 40%, achieving $422 per gram of superfolder...
Nanoplastics Impair GnRH Neuron Migration and Neuroendocrine Function: Emerging Players in the Pathogenesis of Reproductive Disorders
Researchers demonstrated that polystyrene nanoplastics (PS‑NPs) are internalized by gonadotropin‑releasing hormone (GnRH) neurons and disrupt their function. In hormone‑secreting GT1‑7 cells, PS‑NP exposure lowered GnRH release, while in migrating GN11 progenitors it impaired cell movement. Transcriptomic profiling identified altered expression...
Graphene Oxide Nanosheets as Direct Photosensitizers for Photodynamic Therapy in a Size‐Dependent Manner
Researchers discovered that graphene oxide (GO) nanosheets act as direct photosensitizers for photodynamic therapy (PDT) when their lateral size exceeds ~3.5 µm. Under near‑infrared (NIR) irradiation, large GO generates abundant reactive oxygen species (ROS), driving oral squamous cell carcinoma viability down...
Geoff McDonough's Big Plans for NodThera's NLRP3; Enhertu Leader Steps Down at Daiichi
Former Generation Bio CEO Geoff McDonough has joined biotech NodThera to accelerate its NLRP3 inflammasome program, targeting a Phase 3 trial launch next year. The move underscores NodThera’s ambition to capture a fast‑growing market for anti‑inflammatory therapies. In parallel, Daiichi...
Roivant Spinout Priovant Touts Phase 2 Brepocitinib Data in Cutaneous Sarcoidosis
Priovant Therapeutics, a Roivant spin‑out, announced that brepocitinib – an experimental immune modulator inherited from Pfizer – achieved its primary efficacy endpoint in a Phase 2 trial for cutaneous sarcoidosis. The study demonstrated statistically significant reductions in skin lesion severity and...
Post-Hoc Live: Analyzing the Novo Vs. Hims GLP-1 Showdown
Post‑Hoc Live hosted a deep‑dive into the emerging rivalry between Novo Nordisk and Hims & Hers over GLP‑1 therapies. Novo, the long‑time market leader with drugs like Ozempic and Wegovy, faces a new challenger as Hims rolls out a lower‑priced...
STAT+: Roivant Immune Drug Significantly Outperformed Placebo in Treating Rare Skin Disease
Roivant and its spin‑out Priovant reported that brepocitinib dramatically outperformed placebo in a 31‑patient trial for cutaneous sarcoidosis. Patients receiving the high‑dose regimen improved by an average of 22.3 points on a 165‑point disease activity scale, versus just 0.7 points...
Genetically Encoded Sterol‐Modification of a Synthetic Intrinsically Disordered Protein Drives Its Self‐Assembly Into Diverse Morphologies
Researchers engineered a mutant Hedgehog C‑terminal domain to covalently attach five distinct sterols to elastin‑like polypeptides, creating Sterol‑Modified Polypeptides (STaMPs). The sterol’s hydrophobicity (logD) dictates whether the resulting polymer remains monomeric or self‑assembles into spherical micelles. Sterol conjugation also shifts...
Nanomedicine Strategies for Autoimmune Diseases: Targeting and Reprogramming Macrophages
A recent review highlights nanomedicine approaches that target and reprogram macrophages to treat autoimmune diseases. By exploiting nanodrug platforms, researchers can deliver agents directly to pathogenic macrophages, minimizing systemic exposure. The strategy has shown efficacy across rheumatoid arthritis, inflammatory bowel...
An Experimental Surgery Is Helping Cancer Survivors Give Birth
An experimental surgery that temporarily relocates the uterus, ovaries, and fallopian tubes during pelvic radiation allows cancer patients to preserve fertility. The technique, pioneered by Dr. Reitan Ribeiro and adopted by surgeons like Dr. Daniela Huber, has resulted in at...
Illumina Bets on Healthcare After Trump Administration's NIH Funding Disruptions
Illumina announced a strategic pivot toward healthcare customers after the Trump administration’s disruptions to NIH funding slashed research‑sector spending. The company will expand its clinical‑grade sequencing platforms, accelerate partnerships with diagnostic labs, and pursue new reimbursement pathways. Illumina projects its...
Innovative ‘Poop Pills’ Show Promising Results in Clinical Trials for Multiple Types of Cancer
Recent Phase I and II trials demonstrate that oral fecal microbiota transplantation (FMT) capsules can both mitigate immunotherapy‑induced toxicity in kidney cancer and markedly boost response rates in lung cancer and melanoma. In the kidney‑cancer study, 20 patients experienced fewer...
How Eli Lilly’s Biotech Collaboration Model Is Rewriting Early-Stage Innovation
Eli Lilly’s ExploR&D program redefines pharma‑biotech partnerships by offering early‑stage companies shared‑risk, full‑stack R&D support. The model integrates Lilly’s discovery, chemistry, and clinical teams to accelerate the journey from molecule creation to proof‑of‑concept, especially in a tightening funding environment. It focuses...
Carbon Nanotube Artificial Muscles Multistimuli Actuation Mechanisms and Emerging Applications
The review surveys carbon‑nanotube (CNT) artificial muscles, detailing their structural designs—from flat sheets to coiled yarns and core‑sheath hybrids—and the range of multistimuli actuation mechanisms they support. It contrasts voltage‑driven electrochemical actuation with thermal, photothermal, and solvent‑induced pathways, highlighting performance...
Multimodal Phototherapy‐ and Ferroptosis‐Enhanced Ga(III) Supramolecular Nanomicelle for Tumor Theranostics
Researchers have engineered a hierarchically assembled supramolecular nanomicelle with a gallium(III) core that integrates a metal–organic dye (Cy71‑Ga) and a camptothecin‑hyaluronate conjugate (CPT‑HA). The nanomicelle delivers targeted chemotherapy, photothermal/photodynamic therapy, and induces ferroptosis by downregulating xCT and CD98, while also...
Printable Potentiometric Ion‐Selective Electrodes Based on Carbon Fiber and Ti3C2Tx MXene Nanoflakes: Eliminating Complex Modifications
Researchers have developed printable ion‑selective electrodes (ISEs) that replace traditional polyelectrolyte layers with Ti₃C₂Tx MXene nanoflakes on carbon fiber substrates. Two formats were demonstrated: MXene‑only electrodes on glass and screen‑printed MXene ISEs on flexible PVC, both targeting calcium‑ion detection. Tests...
Delivery of Antisense Oligonucleotides Using the Nano‐Cell Vesicle Technology System (nCVTs) for Targeted Cancer Therapy
Researchers introduced Nano‑Cell Vesicle Technology (nCVTs), a hybrid system that merges cationic lipids with tumor‑derived cell membranes to ferry antisense oligonucleotides (ASOs) into cancer cells. The platform achieved superior cytoplasmic and nuclear delivery compared with conventional liposomes and free ASOs,...
Mechanical Threshold‐Guided Harvesting of Microalgal Therapeutics via Designer Nanovesicles
Mechanical threshold‑guided harvesting enables controlled production of designer nanovesicles from microalgae while preserving native carotenoid profiles and boosting antioxidant capacity. The study links vesiculation efficiency to cellular elasticity, identifying critical thresholds of roughly 100 kPa (local) and 390 kPa (global) membrane rigidity....
Design of Experiments (DoE)‐Optimized Polymeric Oxytocin Nanoparticles for Enhanced Nose‐to‐Brain Delivery
Researchers have engineered PEGylated PLGA nanoparticles encapsulating oxytocin for intranasal administration, aiming to improve nose‑to‑brain delivery for autism and related neuropsychiatric conditions. Using a design‑of‑experiments approach, the optimized formulation achieved ~93–116 nm particle size, low polydispersity, and drug loading of 2.8–3.5 %...
This Tiny Molecular Trick Makes Spider Silk Almost Unbreakable
Researchers have identified a specific arginine‑tyrosine interaction that acts as a molecular “sticker” during spider silk formation, explaining how the fiber achieves its legendary strength and elasticity. Using AlphaFold3 modeling, molecular dynamics and NMR spectroscopy, the team showed these interactions...
Latent Labs: AI-Designed, Ready-to-Develop Biologics
Latent Labs, founded by former DeepMind researchers, has unveiled AI platforms that design drug‑like biologics in a single step. Leveraging generative foundation models inspired by AlphaFold2, the London‑based startup creates de novo macrocycles and antibodies for hard‑to‑drug targets. By addressing immunogenicity...
Serendipity Drives Discovery in Psychiatry, Engineering Gets It Across the Line, Says Steve Paul
Steve Paul, a veteran CNS drug developer, argues that engineering breakthroughs—particularly in delivery, selectivity and tolerability—are turning long‑standing psychiatric hypotheses into viable medicines. He notes that psychiatry’s low success rates stem from polygenic disease biology and noisy trials, making human...
Infleqtion Advances to Phase 3 of Wellcome Leap Q4Bio Challenge for Precision Oncology
Infleqtion, together with the University of Chicago and MIT, has entered Phase 3 of the Wellcome Leap Q4Bio Challenge, securing $2 million for a 12‑month validation of quantum‑enabled biomarker discovery. The effort focuses on using the hybrid HRQAOA algorithm to select predictive...
UBE3A Isoform-Selective and Non-Selective Contributions to Angelman Syndrome Phenotypes
Researchers created a mouse model that overexpresses the cytoplasmic UBE3A isoform mIso2 and demonstrated that this manipulation fully rescues most Angelman syndrome (AS) behavioral deficits, including motor coordination, anxiety‑like behavior, and weight gain. However, the same overexpression does not correct...
